医院获得性感染
本文为综述,检索PubMed与OVID同行评议文献及政府机构网站,更新ICU医院获得性感染的病原学(包括新发/新兴病原)、患病率、宿主危险因素、抗菌药物耐药、宿主微生态与感染发生的交互及发病机制与预防策略。作者指出,日益衰老、免疫抑制和衰弱患者的重症监护进展使ICU医院获得性感染总体负担与复杂性增加;病原毒力与耐药性上升要求加大预防力度;医院获得性感染是ICU患者结局的重要决定因素,仍需系统研究改善预防与治疗。
要点
- ICU医院获得性感染在病原(含新发/新兴病原)、患病率、宿主危险因素、耐药、微生态交互、发病机制与预防策略等多维度持续演变。
- 日益衰老、免疫抑制和衰弱的患者接受ICU救治使医院获得性感染总体负担与复杂性增加。
- 医院获得性感染病原毒力与抗菌药物耐药性上升,要求加大预防投入。
- 医院获得性感染是ICU患者结局的重要决定因素。
- 仍需系统研究以改善医院获得性感染的预防与治疗。
适用人群与场景
- ICU内重症患者,尤其日益衰老、免疫抑制和衰弱的个体(原文描述为ICU收治人群特征)。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:综述(updated review)。
- 检索来源:PubMed与OVID的同行评议文献,以及负责医院获得性感染报告与预防的政府机构网站;检索词包括nosocomial infection、antibiotic resistance、microbiome、antibiotics、intensive care。
证据类型、等级与局限
- 证据类型:综述(updated review)。
- 局限:原文未系统说明方法学局限;作为叙述性综述,未提供定量合并或偏倚评估。
对床旁实践的改变
- 提示急诊/ICU应关注医院获得性感染病原谱(含新发/新兴病原)与抗菌药物耐药的持续演变。
- 提示对衰老、免疫抑制和衰弱患者应重视医院获得性感染的总体负担与复杂性。
- 强调病原毒力与耐药性上升背景下需加大预防投入。
- 原文未给出具体可改变的操作性推荐或剂量方案。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The first 70 years of critical care can be considered a period of "industrial revolution-like" advancement in terms of progressing the understanding and care of critical illness. Unfortunately, like the industrial revolution's impact on the environment, advancing ICU care of increasingly elderly, immunosuppressed, and debilitated individuals has resulted in a greater overall burden and complexity of nosocomial infections within modern ICUs. Given the rapid evolution of nosocomial infections, the authors provide an updated review.
DATA SOURCES AND STUDY SELECTION: We searched PubMed and OVID for peer-reviewed literature dealing with nosocomial infections in the critically ill, as well as the websites of government agencies involved with the reporting and prevention of nosocomial infections. Search terms included nosocomial infection, antibiotic resistance, microbiome, antibiotics, and intensive care.
DATA EXTRACTION AND DATA SYNTHESIS: Nosocomial infections in the ICU setting are evolving in multiple domains including etiologic pathogens plus novel or emerging pathogens, prevalence, host risk factors, antimicrobial resistance, interactions of the host microbiome with nosocomial infection occurrence, and understanding of pathogenesis and prevention strategies. Increasing virulence and antimicrobial resistance of nosocomial infections mandate increasing efforts toward their prevention.
CONCLUSIONS: Nosocomial infections are an important determinant of outcome for patients in the ICU setting. Systematic research aimed at improving the prevention and treatment of nosocomial infections is still needed.
参考来源
- Kollef MH, Torres A, Shorr AF, et al. Nosocomial Infection. Crit Care Med. 2021. PMID: 33438970. doi:10.1097/CCM.0000000000004783
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。